跳至主要内容
临床试验/NCT01045356
NCT01045356已完成不适用

Pharmacokinetics of Tranexamic Acid (TXA) in Children Undergoing Repair of Congenital Heart Defects Utilizing Cardiopulmonary Bypass

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
1
主要终点
Determine TXA blood levels in children having cardiac surgery with cardiopulmonary bypass. The current dosing recommendations will be utilized.

研究概览

简要总结

The purpose of this study is to measure blood levels of TXA in children having cardiac surgery which requires cardiopulmonary bypass. TXA is used to reduce bleeding during surgery. This study will help determine if the current dosing of TXA results in therapeutic blood levels.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • congenital heart disease requiring surgical repair with cardiopulmonary bypass

排除标准

  • children weighing over 20 kg
  • family does not want to participate in the study

结局指标

主要结局

Determine TXA blood levels in children having cardiac surgery with cardiopulmonary bypass. The current dosing recommendations will be utilized.

时间窗: multiple times thoughout surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark C. Wesley

MD

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验